NCT04146077

Active Surveillance for Low Risk Prostate Cancer

Active Surveillance Methodology for Low Risk Prostate Cancer

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: I.M. Sechenov First Moscow State Medical University · Academic / Other
• Sex: Male
• Age: 50 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

An active surveillance protocol for patients diagnosed low-risk prostate cancer will be held. We plan to use PSA (prostate-specific antigen) testing, DRE (digital rectal examination), TRUS (transrectal ultrasound), MRI (magnetic resonance imaging) and follow-up biopsies to monitor patients and detect cancer progression in time.

Conditions

• Prostate Cancer
• Prostate Adenocarcinoma

Timeline

• Start date: 2019-10-01
• Primary completion: 2024-10-01
• Completion: 2026-10-01
• First posted: 2019-10-31
• Last updated: 2021-07-22

Locations

1 site across 1 country: Russia